Archimedes Pharma UK Overview

  • Founded
  • 1996

  • Status
  • Acquired/​Merged

  • Employees
  • 23

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Archimedes Pharma UK General Information


Provider of pharmaceutical products. The company offers Gliadel, a treatment for high-grade gliomas; Zomorph for cancer pain; Nozinan, an anti-emetic for nausea and vomiting in advanced cancer patients; and Pabrinex, a high-potency formulation of vitamins B and C for chronic alcoholics. It operates in the United Kingdom, France, and Germany.

Contact Information

Formerly Known As
Link Holdings
Ownership Status
Financing Status
Formerly PE-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 250 South Oak Way
  • Green Park
  • Reading RG2 6UG
  • England, United Kingdom
+44 0118 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Archimedes Pharma UK Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Archimedes Pharma UK‘s full profile, request access.

Request a free trial

Archimedes Pharma UK Board Members (1)

Name Representing Role Since
000 000 Self Board Member 000 0000
To view Archimedes Pharma UK’s complete board members history, request access »

Archimedes Pharma UK Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial